These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 782697)
1. Nitrosoureas as single agents in the treatment of pulmonary cancer. Wolf J Cancer Treat Rep; 1976 Jun; 60(6):753-6. PubMed ID: 782697 [No Abstract] [Full Text] [Related]
3. [Use of nitrosourea compounds in cancer chemotherapy]. Robak T Pol Tyg Lek; 1982 Sep; 37(36):1067-70. PubMed ID: 6763214 [No Abstract] [Full Text] [Related]
4. Nitrosoureas: useful agents for the treatment of advanced gastrointestinal cancer. Douglass HO; Lavin PT; Moertel CG Cancer Treat Rep; 1976 Jun; 60(6):769-80. PubMed ID: 782699 [TBL] [Abstract][Full Text] [Related]
5. Southeastern Cancer Study Group trials with nitrosoureas in Hodgkin's disease. Durant JR; Bartolucci A; Gams RA; Dorfman RF; Velez-Garcia E Cancer Treat Rep; 1976 Jun; 60(6):781-7. PubMed ID: 782700 [TBL] [Abstract][Full Text] [Related]
6. Nitrosoureas: a review of experimental antitumor activity. Schabel FM Cancer Treat Rep; 1976 Jun; 60(6):665-98. PubMed ID: 782694 [TBL] [Abstract][Full Text] [Related]
7. Nitrosoureas in the management of disseminated malignant melanoma. Ahmann DL Cancer Treat Rep; 1976 Jun; 60(6):747-51. PubMed ID: 782696 [TBL] [Abstract][Full Text] [Related]
8. Clinical studies with nitrosoureas in various solid tumors. Slavik M Cancer Treat Rep; 1976 Jun; 60(6):795-800. PubMed ID: 986243 [No Abstract] [Full Text] [Related]
9. Chemotherapy of gynecologic cancer with nitrosoureas: a randomized trial of CCNU and methyl-CCNU in cancers of the cervix, corpus, vagina, and vulva. Omura GA; Shingleton HM; Creasman WT; Blessing JA; Boronow RC Cancer Treat Rep; 1978 May; 62(5):833-5. PubMed ID: 350400 [No Abstract] [Full Text] [Related]
10. [Clinical significance of mustoforan in management of malignant glioma]. Kobiakov GL Vopr Onkol; 2007; 53(6):724-9. PubMed ID: 18416147 [No Abstract] [Full Text] [Related]
11. Clinical comparison of the nitrosoureas. Wasserman TH; Slavik M; Carter SK Cancer; 1975 Oct; 36(4):1258-68. PubMed ID: 1100221 [TBL] [Abstract][Full Text] [Related]
12. Emergence of nitrosourea resistant sublines of Lewis lung tumour following MeCCNU treatment in vivo. Stephens TC; Adams K; Peacock JH Br J Cancer; 1986 Feb; 53(2):237-45. PubMed ID: 3954945 [TBL] [Abstract][Full Text] [Related]
13. The nitrosoureas: carmustine (BCNU) and lomustine (CCNU). Weiss RB; Issell BF Cancer Treat Rev; 1982 Dec; 9(4):313-30. PubMed ID: 6762924 [No Abstract] [Full Text] [Related]
14. [Cancer chemotherapy with special reference to pharmacokinetics of nitrosoureas]. Wakui A Gan To Kagaku Ryoho; 1982 Aug; 9(8):1327-38. PubMed ID: 6223595 [TBL] [Abstract][Full Text] [Related]
15. Nitrosoureas: important new drugs for the treatment of cancer. Salmon SE Ariz Med; 1976 Feb; 33(2):102-4. PubMed ID: 1275737 [No Abstract] [Full Text] [Related]
16. Nitrosourea chemotherapy for primary malignant gliomas. Levin VA; Wilson CB Cancer Treat Rep; 1976 Jun; 60(6):719-24. PubMed ID: 954010 [No Abstract] [Full Text] [Related]
17. [Combination chemotherapy of transplanted rat leukemia L 5222 with 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) and cyclophosphamide (CPA) as well as with methyl-CCNU and CPA (author's transl)]. Zeller WJ; Berger M Arzneimittelforschung; 1981; 31(2):303-5. PubMed ID: 7194646 [TBL] [Abstract][Full Text] [Related]
18. Therapy for gastrointestinal cancer with the nitrosoureas alone and in drug combination. Moertel CG; Schutt AJ; Reitemeier RJ; Hahn RG Cancer Treat Rep; 1976 Jun; 60(6):729-32. PubMed ID: 954012 [No Abstract] [Full Text] [Related]